SNYDER CAPITAL MANAGEMENT L P
Position in CRL — Charles River Laboratories International, Inc.
CIK 1050477
San Francisco, CA
Position in CRL
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$41,004,112
-$7,063,187 QoQ
Shares Held
237,705
-1.4% QoQ
Ownership
0.493%
of shares outstanding
% of Portfolio
0.80%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in CRL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026SNYDER CAPITAL MANAGEMENT L P holds $89,007,423 across 2 Diagnostics & Research names. CRL ranks #2 (46.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
97,661 | $48,003,311 | |
| 2 | CRL |
Charles River Laboratories International, Inc.
This page
|
237,705 | $41,004,112 |
All Filings in CRL
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $41,004,112 | 237,705 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $48,067,299 | 240,963 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $27,835,485 | 177,908 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $27,479,365 | 181,107 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $26,229,464 | 174,259 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $32,845,324 | 177,927 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $30,302,061 | 153,841 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $28,021,130 | 135,643 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $37,430,658 | 138,146 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $34,831,648 | 147,342 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $30,344,367 | 154,834 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $32,666,122 | 155,368 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $32,765,073 | 162,348 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $32,728,797 | 150,201 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $30,010,622 | 152,493 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $33,378,464 | 155,996 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $35,782,775 | 126,009 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $46,027,821 | 122,161 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $56,549,820 | 137,034 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $43,799,637 | 118,403 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $38,179,885 | 131,732 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $33,199,148 | 132,871 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $30,302,180 | 133,814 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $23,720,666 | 136,052 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $17,225,267 | 136,481 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||